IMMUNE MONITORING & FLOW CYTOMETRY SHARED RESOURCE (IM&FCSR) The Immune Monitoring and Flow Cytometry Shared Resource (IM&FCSR) provides investigators with services and research expertise, supporting a wide range of laboratory and clinical studies in cancer immunology and immunotherapy, transplant biology, infectious disease, and vaccine development. The IM&FCSR produces custom-made tetramer complexes of specific peptide and major histocompatibility complex molecules as unique reagents for assessing antigen-specific T cells and isolating these T cells for therapy trials. Our flow cytometry service offers a wide range of instrumentation, from single-laser benchtop analyzers to complex multi-laser cell sorters. We provide protocol-specific, flow cytometric immune monitoring to support immunotherapy trials. We quantify cytokine proteins, as a measure of immune and other cellular function, at technology platforms of high multiplicity, single cell, and/or ultrasensitivity. We perform specific cellular and molecular assays of native and genetically engineered T cells for laboratory research studies and for monitoring clinical samples. Technical assistance is available for data evaluation and interpretation, as is assistance in optimal experimental design. The different dataset we can provide enable the characterization of immune cell?s phenotypes and functionality, determining immune responses and tracking, and monitoring of immune cell products during immunotherapies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-46
Application #
10125958
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-01
Project End
2024-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Graves, Scott S; Parker, Maura H; Stone, Diane et al. (2018) Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:50-54
Gauthier, Jordan; Turtle, Cameron J (2018) Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy. Curr Res Transl Med 66:50-52
Amundsen, Susan K; Smith, Gerald R (2018) The RecB helicase-nuclease tether mediates Chi hotspot control of RecBCD enzyme. Nucleic Acids Res :
Méndez, Eduardo; Rodriguez, Cristina P; Kao, Michael C et al. (2018) A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 24:2740-2748
Buckley, Sarah A; Percival, Mary-Elizabeth; Othus, Megan et al. (2018) A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. Leuk Lymphoma :1-7
Montgomery, Elizabeth T; Noguchi, Lisa M; Dai, James Y et al. (2018) Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States. AIDS Behav 22:402-411
Talarico, Sarah; Leverich, Christina K; Wei, Bing et al. (2018) Increased H. pylori stool shedding and EPIYA-D cagA alleles are associated with gastric cancer in an East Asian hospital. PLoS One 13:e0202925
Rañola, John Michael O; Liu, Quanhui; Rosenthal, Elisabeth A et al. (2018) A comparison of cosegregation analysis methods for the clinical setting. Fam Cancer 17:295-302
Greenbaum, Adam M; Green, Damian J; Holmberg, Leona A et al. (2018) Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma. Blood Res 53:223-226
Zhao, Shanshan; Leonardson, Amy; Geybels, Milan S et al. (2018) A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. Prostate :

Showing the most recent 10 out of 1267 publications